Azalon, f.k.a. Zelos, Inks $4.5M
Azelon Pharmaceuticals, formerly known as Zelos Therapeutics, has raised $4.5 million in Series A financing as part of a corporate restructuring, the company announced Tuesday. Prospect Venture Partners led the round. Other Azelon investors are Lighthouse Capital Partners and Covington Venture Fund.
11 October 2011•2 mins read
